Synopsis
0
CEP/COS
0
JDMF
0
KDMF
0
EDQM
0
USP
0
JP
0
Others
0
FDA Orange Book
0
Europe
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]NDC API
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]VMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]INTERMEDIATE SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Canada
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Related Excipient Companies
Boai NKY Pharmaceuticals Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Actylis
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Ashland
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]CD Formulation
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Gangwal Chemicals
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Microlex e.U
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Novo Excipients
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pharmatrans-Sanaq
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pluviaendo
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Shanghai Welltone Material Technology Co., Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Fillers, Diluents & Binders
Solubilizers
Granulation
Parenteral
Controlled & Modified Release
Direct Compression
Lubricants & Glidants
Coating Systems & Additives
Emulsifying Agents
Disintegrants & Superdisintegrants
Thickeners and Stabilizers
Topical
Film Formers & Plasticizers
Market Place
ABOUT THIS PAGE
80
PharmaCompass offers a list of Danofloxacin Mesylate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Danofloxacin Mesylate manufacturer or Danofloxacin Mesylate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Danofloxacin Mesylate manufacturer or Danofloxacin Mesylate supplier.
PharmaCompass also assists you with knowing the Danofloxacin Mesylate API Price utilized in the formulation of products. Danofloxacin Mesylate API Price is not always fixed or binding as the Danofloxacin Mesylate Price is obtained through a variety of data sources. The Danofloxacin Mesylate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Danofloxacin Mesylate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Danofloxacin Mesylate, including repackagers and relabelers. The FDA regulates Danofloxacin Mesylate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Danofloxacin Mesylate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Danofloxacin Mesylate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Danofloxacin Mesylate supplier is an individual or a company that provides Danofloxacin Mesylate active pharmaceutical ingredient (API) or Danofloxacin Mesylate finished formulations upon request. The Danofloxacin Mesylate suppliers may include Danofloxacin Mesylate API manufacturers, exporters, distributors and traders.
click here to find a list of Danofloxacin Mesylate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Danofloxacin Mesylate DMF (Drug Master File) is a document detailing the whole manufacturing process of Danofloxacin Mesylate active pharmaceutical ingredient (API) in detail. Different forms of Danofloxacin Mesylate DMFs exist exist since differing nations have different regulations, such as Danofloxacin Mesylate USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Danofloxacin Mesylate DMF submitted to regulatory agencies in the US is known as a USDMF. Danofloxacin Mesylate USDMF includes data on Danofloxacin Mesylate's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Danofloxacin Mesylate USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Danofloxacin Mesylate suppliers with USDMF on PharmaCompass.
A Danofloxacin Mesylate written confirmation (Danofloxacin Mesylate WC) is an official document issued by a regulatory agency to a Danofloxacin Mesylate manufacturer, verifying that the manufacturing facility of a Danofloxacin Mesylate active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Danofloxacin Mesylate APIs or Danofloxacin Mesylate finished pharmaceutical products to another nation, regulatory agencies frequently require a Danofloxacin Mesylate WC (written confirmation) as part of the regulatory process.
click here to find a list of Danofloxacin Mesylate suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Danofloxacin Mesylate as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Danofloxacin Mesylate API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Danofloxacin Mesylate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Danofloxacin Mesylate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Danofloxacin Mesylate NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Danofloxacin Mesylate suppliers with NDC on PharmaCompass.
Danofloxacin Mesylate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Danofloxacin Mesylate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Danofloxacin Mesylate GMP manufacturer or Danofloxacin Mesylate GMP API supplier for your needs.
A Danofloxacin Mesylate CoA (Certificate of Analysis) is a formal document that attests to Danofloxacin Mesylate's compliance with Danofloxacin Mesylate specifications and serves as a tool for batch-level quality control.
Danofloxacin Mesylate CoA mostly includes findings from lab analyses of a specific batch. For each Danofloxacin Mesylate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Danofloxacin Mesylate may be tested according to a variety of international standards, such as European Pharmacopoeia (Danofloxacin Mesylate EP), Danofloxacin Mesylate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Danofloxacin Mesylate USP).
Contact Us!
